» Articles » PMID: 35012014

Early Reconstitution of Antibody Secreting Cells After Allogeneic Stem Cell Transplantation

Overview
Journal J Clin Med
Specialty General Medicine
Date 2022 Jan 11
PMID 35012014
Authors
Affiliations
Soon will be listed here.
Abstract

Immune cell reconstitution after stem cell transplantation is allocated over several stages. Whereas cells mediating innate immunity recover rapidly, adaptive immune cells, including T and B cells, recover slowly over several months. In this study we investigated kinetics and reconstitution of de novo B cell formation in patients receiving CD3 and CD19 depleted haploidentical stem cell transplantation with additional in vivo T cell depletion with monoclonal anti-CD3 antibody. This model enables a detailed in vivo evaluation of hierarchy and attribution of defined lymphocyte populations without skewing by mTOR- or NFAT-inhibitors. As expected CD3 T cells and their subsets had delayed reconstitution (<100 cells/μL at day +90). Well defined CD19 B lymphocytes of naïve and memory phenotype were detected at day +60. Remarkably, we observed a very early reconstitution of antibody-secreting cells (ASC) at day +14. These ASC carried the HLA-haplotype of the donor and secreted the isotypes IgM and IgA more prevalent than IgG. They correlated with a population of CD19 CD27 CD38 CD138 cells. Of note, reconstitution of this ASC occurred without detectable circulating T cells and before increase of BAFF or other B cell stimulating factors. In summary, we describe a rapid reconstitution of peripheral blood ASC after CD3 and CD19 depleted haploidentical stem cell transplantation, far preceding detection of naïve and memory type B cells. Incidence before T cell reconstitution and spontaneous secretion of immunoglobulins allocate these early ASC to innate immunity, eventually maintaining natural antibody levels.

References
1.
Antin J, Emerson S, MARTIN P, Gadol N, Ault K . Leu-1+ (CD5+) B cells. A major lymphoid subpopulation in human fetal spleen: phenotypic and functional studies. J Immunol. 1986; 136(2):505-10. View

2.
Tsay G, Zouali M . The Interplay Between Innate-Like B Cells and Other Cell Types in Autoimmunity. Front Immunol. 2018; 9:1064. PMC: 5964140. DOI: 10.3389/fimmu.2018.01064. View

3.
Bader P, Beck J, Frey A, Schlegel P, Hebarth H, Handgretinger R . Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT. Bone Marrow Transplant. 1998; 21(5):487-95. DOI: 10.1038/sj.bmt.1701119. View

4.
Marie-Cardine A, Divay F, Dutot I, Green A, Perdrix A, Boyer O . Transitional B cells in humans: characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation. Clin Immunol. 2008; 127(1):14-25. DOI: 10.1016/j.clim.2007.11.013. View

5.
van der Maas N, Berghuis D, van der Burg M, Lankester A . B Cell Reconstitution and Influencing Factors After Hematopoietic Stem Cell Transplantation in Children. Front Immunol. 2019; 10:782. PMC: 6473193. DOI: 10.3389/fimmu.2019.00782. View